Amended Statement of Ownership: Solicitation (sc 14d9/a)
2013年4月4日 - 6:19AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(RULE 14d-101)
SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION
14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
OBAGI MEDICAL PRODUCTS, INC.
(Name of Subject Company)
OBAGI MEDICAL
PRODUCTS, INC.
(Name of Person(s) Filing Statement)
Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)
67423R108
(CUSIP Number of Class of Securities)
Laura B. Hunter
Vice President, General Counsel
and Secretary
3760 Kilroy Airport Way, Suite 500
Long Beach, CA 90806
(562) 628-1007
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications on Behalf of the Person(s) Filing Statement)
Copies to:
Wesley C. Fredericks
Kevin T. Collins
Jason M. Casella
Jenner & Block LLP
919 Third Avenue
New York, NY 10022-3908
(212) 891-1600
¨
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
Item 9 of the Initial Schedule 14D-9 is hereby amended and supplemented by adding the following Exhibits:
|
|
|
Exhibit No.
|
|
Description
|
|
|
(a)(5)(D)
|
|
Press Release issued by the Company on April 3, 2013 (incorporated by reference to Exhibit 99.1 of the Current Report on Form 8-K filed by the Company on April 3,
2013).
|
|
|
(e)(10)
|
|
Amendment to Agreement and Plan of Merger, dated as of April 3, 2013, among Parent, Purchaser, Valeant (solely for purposes of Section 6.17 thereof) and the Company (incorporated by
reference to Exhibit 2.1 of the Current Report on Form 8-K filed by the Company on April 3, 2013).
|
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
OBAGI MEDICAL PRODUCTS, INC.
|
|
|
|
|
|
By:
|
|
/s/ Albert F. Hummel
|
|
|
|
|
Name: Albert F. Hummel
|
|
|
|
|
Title:
President & Chief Executive Officer
|
Dated: April 3, 2013
|
|
|
|
|
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
過去 株価チャート
から 5 2024 まで 6 2024
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Obagi Medical Products, Inc. (MM) (ナスダック市場): 0 recent articles
その他のObagi Medical Products, Inc.ニュース記事